July 1, 2013. Going forward the indexes will be updated quarterly, with the next update scheduled for the end of September 2013.
July 1, 2013
June saw a little bit of what appeared to be profit taking with the CSPI and ESPI, both flat for the month. In costrast the DDI was up a very robust 9%. For the year all indexes are up strongly, ranging from 21% to 32%, in terms of market capitalization.
We are Drug Delivery specialists with a focus on understanding new products and markets to ensure an optimal fit. Our services range from consulting and resource help (Pharmanumbers), to industry analysis and reports (Bionumbers).
Pharmanumbers provides companies with consulting and resource help. Our clients cover the full spectrum of biopharma companies, from start-ups to companies that are commercially successful and profitable. We provide hands on support and resources in the areas of business and corporate development, with a focus on new product planning, sales and profitability forecasting, as well as deal term development and evaluation.
Bionumbers prepares industry analyses and reports that go beyond the expected to uncover the key parameters and factors impacting product development success and prfitability. Our most recent report DDEP2011, analyzes the Drug Delivery business from the perspective of pipeline success rates, clinical development times and a number of commercial sucess parameters such as sales, prescriptions, and market exclusivity periods. These are the numbers that companies and investors need to understand if they hope to develop profitable new products that meet budgets and timelines.
Looking for the Bionumbers Market Cap Index? You can find it at the Bionumbers Index tab.